Recorded a net loss of $48.4 million, or $0.20 per share, closely aligning closely with the estimated loss of $51.02 million ...

Lexicon Pharmaceuticals (NASDAQ: LXRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.17 per share a year ago.

Yigal Nochomovitz, an analyst from Citi, maintained the Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report). The associated ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) just reported results for the first quarter of 2024.Lexicon Pharmaceuticals reported ...

THE WOODLANDS, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended March 31, 2024 and provided an update ...

Fintel reports that on April 30, 2024, Leerink Partners initiated coverage of Lexicon Pharmaceuticals (NasdaqGS:LXRX) with a ...

The The Woodlands, Texas-based company said it had a loss of 20 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

By Chris Wack Lexicon Pharmaceuticals said that Lonnel Coats has provided notice of his retirement as chief executive officer and member of the board ...

The 36-month beta value for LXRX is at 1.38. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 3 rating it as “overweight,” 3 as “hold,” and 0 as “sell.” The public float ...

Lexicon Institute of Media & Animation (Lexicon IMA) is revolutionizing media education in Pune by offering students ...

LITTLE ROCK (KATV) — Lexicon, Inc. hosted the American Welding Society at Mills University Studies High School on Friday to inspire and inform students of all the opportunities in the welding ...

THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Lexicon Pharmaceuticals Inc. (LXRX) on Thursday reported a loss of $48.4 million in its first quarter. The The Woodlands, Texas-based ...